CRISIL - Fundamental Analysis: Financial Health & Valuation
← Back to ListKey Parameters
⭐ Fundamental Rating: 2.3
Show all parameters (20 more)
🏭 Industry
The credit rating agency sector is generally characterized by high barriers to entry and significant regulatory oversight, resulting in relatively stable margins and predictable revenue streams. Competition within this industry tends to be based on reputation, expertise, and market share, demanding consistent service quality and innovation for long-term survival.
✅ Positive
CRISIL demonstrates robust profit growth, increasing from 113 Cr to 166 Cr over the past two quarters. The company’s strong ROCE of 31.9% indicates effective capital utilization and a high return on invested capital. Furthermore, the low debt-to-equity ratio of 0.14 suggests a conservative capital structure that supports financial flexibility.
⚠️ Limitation
The significantly elevated P/E ratio of 60.2 compared to the industry average of 24.1 raises concerns about potential overvaluation. This high valuation necessitates careful monitoring of future growth rates and margin sustainability, as any slowdown in profitability could trigger a correction. Additionally, the recent downgrade by MarketsMOJO introduces an element of uncertainty regarding future outlooks, although it doesn't immediately impact the balance sheet metrics.
📉 Company Negative News
The MarketsMOJO downgrade indicates negative sentiment surrounding CRISIL’s valuation and technical indicators, potentially dampening investor confidence and increasing price volatility.
📈 Company Positive News
Despite the downgrade, the stock price increased by 2.08% following the news release, suggesting some investors believe the concerns are overblown or that the company's fundamentals remain strong enough to withstand the negative sentiment.
🧾 Long-Term Outlook
We recommend an entry zone between 4,300 ₹ and 4,500 ₹, representing a potential undervaluation given the current price compared to industry peers. For long-term holding guidance, closely monitor CRISIL’s revenue growth trajectory, particularly its ability to maintain its high ROCE. The elevated valuation warrants a disciplined approach—selling should be considered if profitability declines significantly or if the P/E ratio rises further above 70, signaling a potential loss of investor confidence and correction in the stock price. Overall, the company presents moderate risk given its strong financial performance and limited debt burden, but vigilance regarding valuation and growth prospects is paramount.